Therefore, stathmin has attracted the attention of many investigators because of its high level of expression in many types of cancer, including leukemia and lymphoma (Hanash et al, 1988; Luo et al, 1991; Ghosh et al, 1993; Roos et al, 1993), prostate carcinoma (Friedrich et al, 1995), ovarian carcinoma (Price et al, 2000), Wilms' tumour (Takahashi et al, 2002), breast carcinoma (Bieche et al, 1998), and adenoid cystic carcinoma of the salivary glands (Nakashima et al, 2005). Here, STMN1 is linked to ovarian carcinoma.